• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diligent Medical Activities of a Publicly Designated Medical Institution for Infectious Diseases Pave the Way for Overcoming COVID-19: A Positive Message to People Working at the Cutting Edge.

作者信息

Nagano Tatsuya, Arii Jun, Nishimura Mitsuhiro, Yoshida Naofumi, Iida Keiji, Nishimura Yoshihiro, Mori Yasuko

机构信息

Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

出版信息

Clin Infect Dis. 2021 Feb 16;72(4):723-724. doi: 10.1093/cid/ciaa694.

DOI:10.1093/cid/ciaa694
PMID:32474577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7314194/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5510/7884800/065745645b1e/ciaa694f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5510/7884800/065745645b1e/ciaa694f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5510/7884800/065745645b1e/ciaa694f0001.jpg

相似文献

1
Diligent Medical Activities of a Publicly Designated Medical Institution for Infectious Diseases Pave the Way for Overcoming COVID-19: A Positive Message to People Working at the Cutting Edge.传染病定点医疗机构的积极抗疫行动为战胜新冠疫情铺平道路：给奋战在一线的工作者的正能量信息。
Clin Infect Dis. 2021 Feb 16;72(4):723-724. doi: 10.1093/cid/ciaa694.
2
Does SARS-CoV-2 truly cause infectious myopathy?新型冠状病毒真的会引发感染性肌病吗？
J Formos Med Assoc. 2021 Mar;120(3):1032-1033. doi: 10.1016/j.jfma.2020.08.041. Epub 2020 Sep 1.
3
Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis.新冠疫情期间传染病发病率下降：一种假设。
Med Hypotheses. 2021 Jan;146:110465. doi: 10.1016/j.mehy.2020.110465. Epub 2020 Dec 22.
4
What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?2020 年除了 COVID-19 之外，传染病和抗感染治疗领域还发生了哪些变化？
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):8-11. doi: 10.37201/req/s01.02.2021. Epub 2021 Sep 30.
5
How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?要利用被忽视的传染病复制新冠疫苗的成功究竟会有多容易？
BMJ. 2021 Mar 10;372:n678. doi: 10.1136/bmj.n678.
6
Response to letter to the editor "Does SARS-CoV-2 truly cause infectious myopathy?".对致编辑信《严重急性呼吸综合征冠状病毒2型真的会导致感染性肌病吗？》的回复
J Formos Med Assoc. 2021 Mar;120(3):1034-1035. doi: 10.1016/j.jfma.2020.08.046. Epub 2020 Sep 10.
7
[Detection and evaluation of SARS-CoV-2 nucleic acid contamination in corona virus disease 19 ward surroundings and the surface of medical staff's protective equipment].[新型冠状病毒肺炎病房环境及医务人员防护用品表面严重急性呼吸综合征冠状病毒2核酸污染的检测与评估]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Oct 18;52(5):803-808. doi: 10.19723/j.issn.1671-167X.2020.05.002.
8
Use of personal protective equipment reduces the risk of contamination by highly infectious diseases such as COVID-19.使用个人防护装备可降低感染 COVID-19 等高传染性疾病的风险。
Evid Based Nurs. 2021 Apr;24(2):41. doi: 10.1136/ebnurs-2020-103304. Epub 2020 Aug 11.
9
[Report of the Global Committee, a Survey of International Conferences Held Online due to the Effects of COVID-19 Infectious Diseases].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2021;77(3):295-302. doi: 10.6009/jjrt.2021_JSRT_77_3.295.
10
The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.新冠疫情防控措施对台湾地区空气传播/飞沫传播传染病的影响。
J Infect. 2021 Mar;82(3):e30-e31. doi: 10.1016/j.jinf.2020.11.029. Epub 2020 Nov 26.

引用本文的文献

1
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.评估 2 至 3 剂 BNT162b2 mRNA COVID-19 疫苗后针对 SARS-CoV-2 变异株的中和抗体反应。
JAMA Netw Open. 2022 May 2;5(5):e2210780. doi: 10.1001/jamanetworkopen.2022.10780.
2
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan.新冠患者体内针对SARS-CoV-2变异株的交叉中和活性：日本疫情4个阶段的比较
Open Forum Infect Dis. 2021 Aug 18;8(10):ofab430. doi: 10.1093/ofid/ofab430. eCollection 2021 Oct.
3

本文引用的文献

1
Responding to the COVID-19 Outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems.应对新加坡 COVID-19 疫情：员工保护和员工体温及疾病监测系统。
Clin Infect Dis. 2020 Nov 5;71(8):1947-1952. doi: 10.1093/cid/ciaa468.
2
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
3
Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020.
Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19.
新冠患者中克隆性B细胞受体的mRNA表达大量激增。
Heliyon. 2021 Aug;7(8):e07748. doi: 10.1016/j.heliyon.2021.e07748. Epub 2021 Aug 10.
4
Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia.印度尼西亚东爪哇省 SARS-CoV-2 感染的血清流行病学研究。
PLoS One. 2021 May 6;16(5):e0251234. doi: 10.1371/journal.pone.0251234. eCollection 2021.
5
What medical waste management system may cope With COVID-19 pandemic: Lessons from Wuhan.什么样的医疗废物管理系统可以应对新冠疫情：来自武汉的经验教训。
Resour Conserv Recycl. 2021 Jul;170:105600. doi: 10.1016/j.resconrec.2021.105600. Epub 2021 Mar 31.
6
Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan.医院中具有中和活性的严重急性呼吸综合征冠状病毒2抗体的血清流行病学调查：日本兵库县的一项横断面研究
JMA J. 2021 Jan 29;4(1):41-49. doi: 10.31662/jmaj.2020-0094. Epub 2021 Jan 14.
7
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients.不同严重程度新型冠状病毒肺炎患者针对严重急性呼吸综合征冠状病毒2的中和抗体反应及细胞因子/趋化因子释放：尽管危重症患者病毒消失，但细胞因子风暴仍然存在
JMA J. 2021 Jan 29;4(1):1-7. doi: 10.31662/jmaj.2020-0083. Epub 2021 Jan 14.
8
SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control.日本一家收治新冠肺炎患者的综合医院医护人员中SARS-CoV-2 IgG血清流行率：医院感染控制的回顾性评估
J Hosp Infect. 2021 Jan;107:103-104. doi: 10.1016/j.jhin.2020.10.001. Epub 2020 Oct 9.
估算 2020 年日本横滨钻石公主号游轮上的 2019 年冠状病毒病（COVID-19）病例的无症状比例。
Euro Surveill. 2020 Mar;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180.